Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Okta Stock Looks Dangerous at This Point

By Will Healy, InvestorPlace Contributor
Okta's signature product should generate massive growth in the long-term, but buying OKTA stock now is dangerous.

3 Stocks to Sell and Kiss Goodbye Before the New Year

By Chris Markoch, InvestorPlace Contributor
When a stock gets a sell rating, it’s important to get out before further damage is done to your portfolio. That said, take a look at these three stocks to sell before we enter 2020.

This Is As Good As It Gets for Advanced Micro Devices Stock

By Ian Bezek, InvestorPlace Contributor
Everything has gone right for Advanced Micro Devices stock lately. Unfortunately, that means that the company is out of catalysts for further gains.

Plug Power Stock Is Hitting a Science Problem Heading into 2020

By Josh Enomoto, InvestorPlace Contributor
PLUG stock has more than doubled in market value so far in 2019. But in the long run, the underlying company faces a science risk.

Does the Real MEAT Act Help or Hurt Beyond Meat?

By Chris Markoch, InvestorPlace Contributor
The real meat industry’s efforts to counter Beyond Meat’s influence may not kill BYND stock. However, it adds another distraction that the plant-based meat company doesn’t need.

This Latest Correction Does Not Make Aurora Stock Attractive

By Faisal Humayun, InvestorPlace Contributor
Regulatory hurdles pose a major challenge for cannabis industry growth. Cash burn is likely to sustain and more equity dilution expected.

Nokia Margin Compression Leaves Us Bearish on the 5G Name Well Into 2020

By Faisal Humayun, InvestorPlace Contributor
Lower guidance for 2019 and 2020 along with margin concerns. 5G is the hope for turnaround beyond 2020. Cash burn remains a concern.

How Many Ways Can We Say ‘No’ to Nio Stock?

By Dana Blankenhorn, InvestorPlace Contributor
Nio delivered 2,500 electric vehicles in November, but it may not be enough for Nio stock to survive in China's competitive market.

The Clock Is Ticking for Aurora Cannabis After a Tough Year

By Dana Blankenhorn, InvestorPlace Contributor
Aurora Cannabis hopes that CBD oil and converting debt to equity can save it from the scrap heap.

Groupon’s Turnaround Hopes Are Too Dim to Save Groupon Stock

By Vince Martin, InvestorPlace Contributor
Groupon stock is cheap, but its cheapness looks justified. Real questions about GRPN's operating model make GRPN stock a sell.

It Doesn’t Look as If 2020 Will Be Any Better for Hexo Stock

By Faisal Humayun, InvestorPlace Contributor
Cash burn will result in equity dilution. Slower growth likely in medicinal and recreational cannabis due to regulatory headwinds.

Deal or No Deal, Chesapeake Energy is DOA 

By Will Ashworth, InvestorPlace Contributor
At this point, anyone still holding Chesapeake stock is either an insider or employee, a massive risk-taker, or wildly delusional.

A Close Look Shows New Age Beverages Stock Remains a Sell

By Vince Martin, InvestorPlace Contributor
NBEV stock is intriguing as its revenue is growing and it has a CBD opportunity. But NBEV is failing to deliver on its promise.

Investors Should Ignore Disastrous Nokia Stock and Its Yield Trap

By Dana Blankenhorn, InvestorPlace Contributor
With 5G, Nokia should have been a winner in 2019. Instead, it's struggling and losing money. I'd rather own the Mets than NOK stock.

Amazon Will Get Back To Winning Ways, But Not Yet

By Luke Lango, InvestorPlace Senior Investment Analyst
Amazon will head higher in the long run, but escalating competitive pressures will weigh on shares in the near term.

I’ve Done the Math on Snap Stock … Its ARPU Stats Add Up to Overvalued

By Mark R. Hake, CFA
Snapchat stock is overvalued based on its recent ARPU stats. And an impatient market wants to see profits, either on an EBITDA or free cash flow basis.

The Price of Karuna Therapeutics Stock Is Too Tough to Swallow

By Josh Enomoto, InvestorPlace Contributor
In just a matter of a single day, KRTX stock skyrocketed to triple-digit gains. However, Karuna Therapeutics remains a risky pharma play when all is said and done.

Aurora Cannabis Will Survive, But It’s Still a Poor Investment

By Ian Bezek, InvestorPlace Contributor
Aurora Cannabis isn't going to go bankrupt soon, so don't worry about that. But those fears show just how far it has fallen.

Why I’m Cautious on Plug Power Stock

By Faisal Humayun, InvestorPlace Contributor
The guidance offered by PLUG seems overly ambitious. Therefore, investors should avoid PLUG stock.
Load More Articles